ITF 2534Alternative Names: ITF-2534
Latest Information Update: 16 Jul 2016
At a glance
- Originator Italfarmaco
- Class Triazoles
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Aspergillosis; Cryptococcosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Aspergillosis in Italy (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cryptococcosis in Italy (PO)